Updates are available Correction dated 2019-09-06
Click to view Correction: https://doi.org/10.1038/s41564-019-0574-7
-
Authors
Levan, Sophia R.
Stamnes, Kelsey A.
Lin, Din L.
Panzer, Ariane R.
Fukui, Elle
McCauley, Kathryn
Fujimura, Kei E.
McKean, Michelle
Ownby, Dennis R. http://orcid.org/0000-0003-0944-6466
Zoratti, Edward M.
Boushey, Homer A.
Cabana, Michael D. http://orcid.org/0000-0001-9376-2167
Johnson, Christine C.
Lynch, Susan V. http://orcid.org/0000-0001-5695-7336
- License Information
-
More Information
Article History
Received: 26 February 2019
Accepted: 29 May 2019
First Online: 22 July 2019
Change Date: 6 September 2019
Change Type: Correction
Change Details: An amendment to this paper has been published and can be accessed via a link at the top of the paper.
Competing interests
: S.V.L. is co-founder of Siolta Therapeutics Inc., and serves as both a consultant and a member of its Board of Directors. Furthermore, the Regents of the University of California, UCSF have filed a provisional patent application (Application number 62/637,175) on behalf of S.V.L. and S.R.L. relating to the methods and compositions of EH genes.
